Acute hepatitis treatment or preventive / therapeutic agent for fulminant hepatitis

摘要

When acute hepatitis progresses to fulminant hepatitis, hepatocyte destruction occurs rapidly and in large quantities, resulting in a very poor prognosis. Therefore, it is important to predict the progression from acute hepatitis to fulminant as soon as possible and to start appropriate treatment promptly. However, despite the recent improvement in testing methods and diagnostic techniques, it has become possible to predict fulminant hepatitis. An object of the present invention is to provide a therapeutic agent for acute hepatitis or a prophylactic / therapeutic agent for fulminant hepatitis with few side effects. A pharmaceutical composition containing apolipoprotein A-II has solved the above problems. [Selection figure] None